BAL PHARMA
Back to Income Statement
|
BAL PHARMA Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹339 Cr | ₹304 Cr | ₹281 Cr | ₹251 Cr | ₹171 Cr |
What is the latest Revenue of BAL PHARMA ?
Year | Revenue |
---|---|
Mar2024 | ₹339 Cr |
Mar2023 | ₹304 Cr |
Mar2022 | ₹281 Cr |
Mar2021 | ₹251 Cr |
Mar2020 | ₹171 Cr |
How is Revenue of BAL PHARMA Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹339 Cr | 11.51 | |
Mar2023 | ₹304 Cr | 8.18 | |
Mar2022 | ₹281 Cr | 12.25 | |
Mar2021 | ₹251 Cr | 46.43 | |
Mar2020 | ₹171 Cr | - |
Compare Revenue of peers of BAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BAL PHARMA | ₹181.7 Cr | 3.9% | -9.6% | -13.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,228.0 Cr | -2.4% | -7.2% | 27.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹148,023.0 Cr | 0% | -9.2% | 61.5% | Stock Analytics | |
CIPLA | ₹119,474.0 Cr | 6% | -3.8% | 10.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,599.0 Cr | 1.7% | -11.4% | 2.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,604.7 Cr | 5.2% | -2.1% | 26.1% | Stock Analytics |
BAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BAL PHARMA | 3.9% |
-9.6% |
-13.3% |
SENSEX | 1.7% |
-1.3% |
7.7% |
You may also like the below Video Courses